This page is an automatically generated summary of information from the Federal Court, Federal Court of Appeal, Health Canada and other websites. This information should NOT be relied upon as it is automatically generated and has not been confirmed for accuracy.

Automatically generated on January 31, 2023.

Return to the list of Patented Medicine Litigation page.

---

---

Linagliptin

JENTADUETO, TRAJENTA – Boehringer Ingelheim (Canada) Ltd. (NOC Search)

Patents:

• 2370921: PHARMASCIENCE, SANDOZ, APOTEX
• 2435730: PHARMASCIENCE, SANDOZ
• 2496249: SANDOZ, PHARMASCIENCE, RIVA
• 2649922: JAMP, RIVA, PHARMASCIENCE, APOTEX, SANDOZ, TEVA
• 2696558: TEVA, SANDOZ, APOTEX, RIVA, JAMP, PHARMASCIENCE
• 2732803: TEVA, SANDOZ, APOTEX, RIVA, JAMP, PHARMASCIENCE
• 2738367: TEVA, SANDOZ, APOTEX, PHARMASCIENCE, RIVA, JAMP
• 2752437: APOTEX, TEVA, SANDOZ, RIVA, JAMP, PHARMASCIENCE
• 2782179: TEVA, PHARMASCIENCE, JAMP

APOTEX

• PM(NOC) – T-1176-22 – T-1178-22 – T-1181-22 – T-1187-22 – T-1188-22

JAMP

• PM(NOC) – T-788-21

PHARMASCIENCE

• PM(NOC) – T-15-22

RIVA

• PM(NOC) – T-192-23 – T-193-23 – T-194-23 – T-195-23 – T-196-23 – T-197-23

SANDOZ

• PM(NOC) – T-16-21

TEVA

• PM(NOC) – T-1531-20 – T-1533-20

---

Return to the Patented Medicine Litigation page.